This process can take as long as two months. With a single B cell screening platform, however, within a day Biointron can isolate single B cells, and find the ones secreting target antibody molecules.
The Cyto-Mine ® platform by Sphere Fluidics utilizes innovative picodroplet-based technology to capture and screen antibodies directly from entire B cell repertoires, maintaining cell viability ...